Rademakers SE, Hoogsteen IJ, Rijken PF, Oosterwijk E, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende P, Takes R, De Bree R, van der Kogel AJ, Bussink J, Kaanders JH.

Radiother Oncol. 2013 May 26. doi:pii: S0167-8140(13)00197-7. 10.1016/j.radonc.2013.04.022. [Epub ahead of print]

PMID:: 23719582; [PubMed - as supplied by publisher]

Related citations

Select item 236979263.

ImmunoPET Imaging of Renal Cell Carcinoma with ¹²⁴I- and ⁸⁹Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice.

Stillebroer AB, Franssen GM, Mulders PF, Oyen WJ, van Dongen GA, Laverman P, Oosterwijk E, Boerman OC.

Cancer Biother Radiopharm. 2013 May 22. [Epub ahead of print]

PMID:: 23697926; [PubMed - as supplied by publisher]

Related citations

Select item 236387444.

Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma.

Muselaers S, Mulders P, Oosterwijk E, Oyen W, Boerman O.

Immunotherapy. 2013 May;5(5):489-95. doi: 10.2217/imt.13.36.

PMID:: 23638744; [PubMed - in process]

Related citations

Select item 234960315.

Ureteral Tissue Engineering: Where Are We and How to Proceed?

Simaioforidis V, de Jonge P, Sloff M, Oosterwijk E, Geutjes P, Feitz WF.

Tissue Eng Part B Rev. 2013 Apr 25. [Epub ahead of print]

PMID:: 23496031; [PubMed - as supplied by publisher]

Related citations

Select item 234534216.

Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma.

Muselaers CH, Boerman OC, Oosterwijk E, Langenhuijsen JF, Oyen WJ, Mulders PF.

Eur Urol. 2013 Jun;63(6):1101-6. doi: 10.1016/j.eururo.2013.02.022. Epub 2013 Feb 21.

PMID:: 23453421; [PubMed - in process]

Related citations

Select item 234233377.

Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.

Lamers CH, Sleijfer S, van Steenbergen S, van Elzakker P, van Krimpen B, Groot C, Vulto A, den Bakker M, Oosterwijk E, Debets R, Gratama JW.

Mol Ther. 2013 Apr;21(4):904-12. doi: 10.1038/mt.2013.17. Epub 2013 Feb 19.

PMID:: 23423337; [PubMed - in process]

Related citations

Select item 232596828.

Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging.

Ventura M, Sun Y, Rusu V, Laverman P, Borm P, Heerschap A, Oosterwijk E, Boerman OC, Jansen JA, Walboomers XF.

Tissue Eng Part C Methods. 2013 Jun;19(6):405-16. doi: 10.1089/ten.tec.2012.0007. Epub 2012 Dec 21.

PMID:: 23259682; [PubMed - in process]

Related citations

Select item 230699149.

Lyophilisomes as a new generation of drug delivery capsules.

van Bracht E, Raavé R, Verdurmen WP, Wismans RG, Geutjes PJ, Brock RE, Oosterwijk E, van Kuppevelt TH, Daamen WF.

Int J Pharm. 2012 Dec 15;439(1-2):127-35. doi: 10.1016/j.ijpharm.2012.10.008. Epub 2012 Oct 13.

PMID:: 23069914; [PubMed - indexed for MEDLINE]

Related citations

Select item 2304020510.

Potential role of genetic markers in the management of kidney cancer.

Junker K, Ficarra V, Kwon ED, Leibovich BC, Thompson RH, Oosterwijk E.

Eur Urol. 2013 Feb;63(2):333-40. doi: 10.1016/j.eururo.2012.09.040. Epub 2012 Sep 24.

PMID:: 23040205; [PubMed - in process]

Related citations

Select item 2298044111.

Phase 1 Radioimmunotherapy Study with Lutetium 177-labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.

Stillebroer AB, Boerman OC, Desar IM, Boers-Sonderen MJ, van Herpen CM, Langenhuijsen JF, Smith-Jones PM, Oosterwijk E, Oyen WJ, Mulders PF.

Eur Urol. 2012 Aug 21. doi:pii: S0302-2838(12)00959-1. 10.1016/j.eururo.2012.08.024. [Epub ahead of print]

PMID:: 22980441; [PubMed - as supplied by publisher]

Related citations

Select item 2293475512.

Zero echo time magnetic resonance imaging of contrast-agent-enhanced calcium phosphate bone defect fillers.

Sun Y, Ventura M, Oosterwijk E, Jansen JA, Walboomers XF, Heerschap A.

Tissue Eng Part C Methods. 2013 Apr;19(4):281-7. doi: 10.1089/ten.TEC.2011.0745. Epub 2013 Jan 18.

PMID:: 22934755; [PubMed - in process]

Related citations

Select item 2279585913.

In-vivo performance of high-density collagen gel tubes for urethral regeneration in a rabbit model.

Micol LA, Arenas da Silva LF, Geutjes PJ, Oosterwijk E, Hubbell JA, Feitz WF, Frey P.

Biomaterials. 2012 Oct;33(30):7447-55. doi: 10.1016/j.biomaterials.2012.06.087. Epub 2012 Jul 15.

PMID:: 22795859; [PubMed - indexed for MEDLINE]

Related citations

Select item 2270444414.

Tissue engineered tubular construct for urinary diversion in a preclinical porcine model.

Geutjes P, Roelofs L, Hoogenkamp H, Walraven M, Kortmann B, de Gier R, Farag F, Tiemessen D, Sloff M, Oosterwijk E, van Kuppevelt T, Daamen W, Feitz W.

J Urol. 2012 Aug;188(2):653-60. doi: 10.1016/j.juro.2012.03.119. Epub 2012 Jun 15.

PMID:: 22704444; [PubMed - in process]

Related citations

Select item 2248027615.

Improving the cell distribution in collagen-coated poly-caprolactone knittings.

Sun W, Tiemessen DM, Sloff M, Lammers RJ, de Mulder EL, Hilborn J, Gupta B, Feitz WF, Daamen WF, van Kuppevelt TH, Geutjes PJ, Oosterwijk E.

Tissue Eng Part C Methods. 2012 Oct;18(10):731-9. Epub 2012 May 10.

PMID:: 22480276; [PubMed - in process]

Related citations

Select item 2236564016.

Modest improvement in 20 years of kidney cancer care in the Netherlands.

van de Schans SA, Aben KK, Mulders PF, Haanen JB, van Herpen C, Verhoeven RH, Karim-Kos HE, Oosterwijk E, Kiemeney LA.

Eur J Cancer. 2012 Aug;48(12):1822-30. doi: 10.1016/j.ejca.2012.01.033. Epub 2012 Feb 23.

PMID:: 22365640; [PubMed - indexed for MEDLINE]

Related citations

Select item 2234127017.

Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder.

Arentsen HC, Jansen CF, Hulsbergen-van de Kaa CA, Laihia JK, Pylkkänen L, Leino L, Oosterwijk E, Witjes JA.

J Urol. 2012 Apr;187(4):1445-9. doi: 10.1016/j.juro.2011.11.080. Epub 2012 Feb 16.

PMID:: 22341270; [PubMed - in process]

Related citations

Select item 2233360218.

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.

Betof AS, Rabbani ZN, Hardee ME, Kim SJ, Broadwater G, Bentley RC, Snyder SA, Vujaskovic Z, Oosterwijk E, Harris LN, Horton JK, Dewhirst MW, Blackwell KL.

Br J Cancer. 2012 Feb 28;106(5):916-22. doi: 10.1038/bjc.2012.32. Epub 2012 Feb 14.

PMID:: 22333602; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 2230690519.

PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer.

Dulos J, Carven GJ, van Boxtel SJ, Evers S, Driessen-Engels LJ, Hobo W, Gorecka MA, de Haan AF, Mulders P, Punt CJ, Jacobs JF, Schalken JA, Oosterwijk E, van Eenennaam H, Boots AM.

J Immunother. 2012 Feb-Mar;35(2):169-78. doi: 10.1097/CJI.0b013e318247a4e7.

PMID:: 22306905; [PubMed - indexed for MEDLINE]

Related citations

Select item 2215917920.

Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.

Stillebroer AB, Zegers CM, Boerman OC, Oosterwijk E, Mulders PF, O'Donoghue JA, Visser EP, Oyen WJ.

J Nucl Med. 2012 Jan;53(1):82-9. doi: 10.2967/jnumed.111.094896. Epub 2011 Dec 12.

PMID:: 22159179; [PubMed - indexed for MEDLINE]

Free Article

Related citations

<< First< Prev

Page of 8

Next >Last >>

Supplemental Content

Filters: Manage Filters

Titles with your search terms

Words of wisdom. Re: Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Stillebroer AB, Mulders PFA, Boerman DC, Oyen WJG, Oosterwijk. E Eur Urol. In press. DOI: 10.1016/j.eururo.2010.03.015. [Eur Urol. 2010]
Words of wisdom. Re: Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Stillebroer AB, Mulders PFA, Boerman DC, Oyen WJG, Oosterwijk. E Eur Urol. In press. DOI: 10.1016/j.eururo.2010.03.015.
Sciarra A. Eur Urol. 2010 Aug; 58(2):316.

14 free full-text articles in PubMed Central

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification. [Br J Cancer. 2012]
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
Betof AS, Rabbani ZN, Hardee ME, Kim SJ, Broadwater G, Bentley RC, Snyder SA, Vujaskovic Z, Oosterwijk E, Harris LN, et al. Br J Cancer. 2012 Feb 28; 106(5):916-22. Epub 2012 Feb 14.
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. [Nat Genet. 2011]
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.
Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, Prokhortchouk E, Wu X, Kiemeney LA, Gaborieau V, et al. Nat Genet. 2011 Jan; 43(1):60-5. Epub 2010 Dec 5.
Antibody-specific detection of CAIX in breast and prostate cancers. [Biochem Biophys Res Commun. 2009]
Antibody-specific detection of CAIX in breast and prostate cancers.
Li Y, Wang H, Oosterwijk E, Selman Y, Mira JC, Medrano T, Shiverick KT, Frost SC. Biochem Biophys Res Commun. 2009 Aug 28; 386(3):488-92. Epub 2009 Jun 16.